Learning and Teaching Pharmacoeconomics
Salus Vitae Group is hosting a free informational session titled “Learning and Teaching Pharmacoeconomics” on October 15th, 2021.
The session will cover:
Target Audience:
The session is free but registration is required.
The session will cover:
- What is pharmacoeconomics and how is it used
- Obstacle faced when learning, teaching, generating or communicating pharmacoeconomics analyses
- How to overcome these obstacles
Target Audience:
- Educators and learners
- Industry and private sector professionals
- Health system professionals
- National and international organizations professionals
The session is free but registration is required.
Registration
Once you submit your responses, you will be directed to the final page to complete the free enrollment. You will receive a confirmation email once you complete enrollment. This format will allow you to log in and listen to the session once it becomes available. If you log in today, you will not see content under the curriculum tab. The contents of the session will open on October 15th, 2021, at 11 am CST. We recognize everyone’s schedules are different, and we want to make sure to accommodate the variety. Therefore, you will have access to the content until October 31st, 2021.
|
|
Healthcare resources are scarce. How much are you willing to pay to save a life or extend life for a year? What should policymakers and society be willing to pay for an additional or incremental unit of health gain? |
|
If you make any decisions in healthcare, then this book is for you. Anyone who ultimately has the power to make any decision in healthcare needs to equip themselves with the skills to conduct or, at the very least, evaluate outcomes research – of which pharmacoeconomics is a type.
|
|
Pharmacoeconomics is used to inform resource allocation decisions and define effective pharmaceutical policies.
|
The Art of Pharmacoeconomics is the first of its kind book that takes a macro-level approach to the methodology, skills, and personnel needed to perform and evaluate pharmacoeconomics research.
This book speaks to the art, and not just the technical features, of the discipline. It serves as an easy-to-read guide to the key elements that go into the process of conducting and evaluating pharmacoeconomics analyses and provides the reader with the framework and tools needed (including a pharmacoeconomics canvas). |
The objective of the book is that you see the world of healthcare decision-making a little differently.
Dr. Rola Kaakeh, author of “The Art of Pharmacoeconomics,” joined a diverse audience for three webinars to discuss her new book, why you should read it, and how to benefit from the concepts covered to improve healthcare decision-making. The webinars are similar in format, however, vary in the audience questions and conversation.
|
May 26th, 2021
|
May 27th, 2021
|
June 5th, 2021
|
The book is organized into three sections and seven chapters.
|
Section 1: Decision-Making and Pharmacoeconomics - serves as a background and introduces the concept of healthcare resource allocation, value, decision-making, outcomes research, and pharmacoeconomics analyses.
Section 2: Designing, Conducting, and Evaluating Pharmacoeconomics Analyses - goes through the process of designing, conducting, and evaluating pharmacoeconomics analyses. It also features information on how to go about building a team, whom you should consider working/or partnering with, and why. A Pharmacoeconomics Canvas is introduced and summarized. Section 3: Putting it All Together - provides information on abbreviations, references, index, and empty pages for notes. |
|
|
This book is designed for students, residents, fellows, healthcare and public health professionals, and decision-makers. Everyone, regardless of prior expertise or background in pharmacoeconomics and outcomes research, would benefit from learning the skills and fundamentals taught in this book. Learning the art of pharmacoeconomics in the manner addressed in the book will help tell stories of impact through a more objective and evidence-based approach.
|
Readers can use the contents of the book, both in the classroom and in practice, to:
Learn the discipline of pharmacoeconomics and outcomes research Conduct and evaluate pharmacoeconomics studies Supplement existing pharmacoeconomics resources |
Goals of the Book
|
SIMPLIFY
Simplify a complex discipline to break down the skills gaps and competency barriers faced by healthcare professionals. |
|
IMPROVE QUALITY AND USE
Allows the information generated through these analyses to be higher quality and more useful in practice. |
|
|
FUNDAMENTAL UNDERSTANDING
Provide an essential beginner’s fundamental understanding of the principles to articulate, work on, evaluate studies, and use these tools and information in practice and decision-making when needed. |
|
IMPROVE ABILITIES
Improve abilities to understand, interpret, and critically evaluate pharmacoeconomic literature, which will assist in translating the results of the analyses into practice and determine its relevance in healthcare decision-making. |
About the Author
|
Dr. Rola Kaakeh is the CEO of Salus Vitae Group and adjunct faculty at the Northwestern University Feinberg School of Medicine. She is a fellowship-trained licensed pharmacist with nearly 15 years of experience in academic, corporate, and pharmacy practice settings. Dr. Kaakeh advises a wide range of institutions, including universities, corporations, consultancies, professional associations, non-governmental and humanitarian organizations, and startups. Her areas of focus include national policies and institution-specific initiatives that address healthcare topics covering access, delivery, and outcomes. She has won numerous awards and presented on several global stages to address pressing healthcare issues. Dr. Kaakeh started university at the age of 10 as a gifted child, holds a doctorate in pharmacy from Purdue University, and completed a post-doctoral fellowship in pharmaceutical outcomes and health services research from the University of Michigan.
|
The Art of Pharmacoeconomics Press Release
